Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
ONT

Oxford Nanopore Technologies plc

ONTLSEUnited KingdomHealthcareBiotechnologyFTSE 250

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for…more

P/B2.55xROIC-37.9%
£1.19B
Market Cap
EV: £967.69M
MOM1
QUAL4
VAL2
RSK5
ONT
£1.19B
Market Cap · EV £967.69M

Oxford Nanopore Technologies plc

MOM1
QUAL4
VAL2
RSK5

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for…more

Latest RNS from Oxford Nanopore Technologies plc

Analyst consensus: Buy

As of 22 Jul 2026, 12 analysts rate Oxford Nanopore Technologies plc a Buy, with 75% buy ratings and a mean price target of 184p (range 120p–225p), +66% vs the current price.

Strong buy: 4Buy: 5Hold: 3Sell: 0Strong sell: 0

Full analyst history →

More Healthcare companies